Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover

Jul 16, 2026, 1:34 PM

Read Full Article → Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover

Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover

Translate article text

Choose a language and wait for the translated text.

This acquisition marks Eli Lilly’s first move into the psychedelic space as the pharma curates a diversified pipeline.

Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover | PharmaVoice